LASSBio-1749

N/A

Report date: 2023/05/11 13:42:00
NME

Base Information

Drug NameLASSBio-1749
Drug Alias NameLASSBio-1749
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBrazil
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFederal University of Rio de Janeiro
China Registration ClassN/A

Develop Information

Active CompaniesFederal University of Rio de Janeiro
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A